The coronavirus 19 (COVID-19) pandemic and the measures implemented for its control meant the interruption of prenatal care, with potential risk to maternal and fetal health. However, conventional in-person prenatal would imply exposure and risk of infection in patients and health care providers. The Instituto Nacional Materno Perinatal (INMP) has incorporated teleconsultation as part of a new model of mixed prenatal care, which aims to reduce in-person appointments and, therefore, the contact and risk of viral transmission. The prenatal care package performs essential activities to care for pregnant women of specific gestational ages with a greater impact on perinatal and maternal outcomes. This new model could be generalized nationally and be part of the solution to the disparities of healthcare in Peru, through policies for the use of telemedicine in prenatal care that facilitate its ...

La pandemia del coronavirus 19 (COVID-19) y las medidas instauradas para su control significaron la interrupción de la atención prenatal, con potencial riesgo en la salud materna y fetal. Por otro lado, la atención prenatal convencional presencial implicaría exposición y riesgo de infección en pacientes y proveedores de salud. El Instituto Nacional Materno Perinatal (INMP) ha incorporado la teleconsulta como parte de un nuevo modelo de atención prenatal mixto, cuyo objetivo es disminuir las citas presenciales y, por tanto, el contacto y riesgo de transmisión viral. El paquete de atención prenatal incluye actividades esenciales para atender gestantes en edades gestacionales específicas con mayor impacto en los desenlaces perinatales y maternos. Este nuevo modelo podría generalizarse a nivel nacional y ser parte de la solución a las disparidades de atención en el Perú, median...

Preeclampsia is a disease of pregnancy that affects mother and fetus and is responsiblefor a considerable proportion of maternal and perinatal deaths. It complicates 3 to 22% ofpregnancies and is the second leading cause of maternal death in Peru with 32%, as well asthe leading cause of maternal death at the National Maternal Perinatal Institute with 43%. Areview of new contributions on severe preeclampsia and eclampsia management and treatmentof one of its most serious complications liver rupture are done.Keywords: Preeclampsia, eclampsia, HELLP syndrome.

Preeclampsia is a progressive and irreversible disease that affects multiple organs and because it will harm the mother and fetus, is responsible for a considerable proportion of maternal and perinatal deaths. Complicates 3 to 22% of pregnancies and is the second leading cause of maternal death in Peru 2013 with 38%, and the leading cause of maternal death in the National Maternal Perinatal Institute with 43%. The clinical spectrum of preeclampsia ranges from mild to severe forms. The diagnostic criteria of preeclampsia are hypertension and proteinuria, however most Proteinuria 5 g no longer considered as a criterion of severe preeclampsia. Carried out a review of the new contributions in the management of severe preeclampsia and eclampsia and the management of one of its most serious complications sucha as the liver rupture.

Preeclampsia is a disease of pregnancy that affects mother and fetus and is responsiblefor a considerable proportion of maternal and perinatal deaths. It complicates 3 to 22% ofpregnancies and is the second leading cause of maternal death in Peru with 32%, as well asthe leading cause of maternal death at the National Maternal Perinatal Institute with 43%. Areview of new contributions on severe preeclampsia and eclampsia management and treatmentof one of its most serious complications liver rupture are done.Keywords: Preeclampsia, eclampsia, HELLP syndrome.

Preeclampsia is a progressive and irreversible disease that affects multiple organs and because it will harm the mother and fetus, is responsible for a considerable proportion of maternal and perinatal deaths. Complicates 3 to 22% of pregnancies and is the second leading cause of maternal death in Peru 2013 with 38%, and the leading cause of maternal death in the National Maternal Perinatal Institute with 43%. The clinical spectrum of preeclampsia ranges from mild to severe forms. The diagnostic criteria of preeclampsia are hypertension and proteinuria, however most Proteinuria 5 g no longer considered as a criterion of severe preeclampsia. Carried out a review of the new contributions in the management of severe preeclampsia and eclampsia and the management of one of its most serious complications sucha as the liver rupture.

Se sabe que las mujeres embarazadas experimentan cambios inmunológicos y fisiológicos que pueden hacerlas más susceptibles a las infecciones respiratorias virales, incluido COVID-19 (SARS-CoV-2,).  Diversos estudios revelaron que las mujeres embarazadas con diferentes enfermedades respiratorias virales tenían un alto riesgo de desarrollar complicaciones obstétricas y resultados adversos perinatales en comparación con las mujeres no grávidas, debido a los cambios en las respuestas inmunes1-8.  También sabemos que las mujeres embarazadas pueden estar en riesgo de enfermedad grave, morbilidad o mortalidad en comparación con la población general, tal y como se observa en los casos de otras infecciones por coronavirus relacionadas [incluido el coronavirus del síndrome respiratorio agudo severo (SARS-CoV) y el coronavirus del síndrome respiratorio del Medio Oriente (MERS-...

Se sabe que las mujeres embarazadas experimentan cambios inmunológicos y fisiológicos que pueden hacerlas más susceptibles a las infecciones respiratorias virales, incluido COVID-19 (SARS-CoV-2,).  Diversos estudios revelaron que las mujeres embarazadas con diferentes enfermedades respiratorias virales tenían un alto riesgo de desarrollar complicaciones obstétricas y resultados adversos perinatales en comparación con las mujeres no grávidas, debido a los cambios en las respuestas inmunes1-8.  También sabemos que las mujeres embarazadas pueden estar en riesgo de enfermedad grave, morbilidad o mortalidad en comparación con la población general, tal y como se observa en los casos de otras infecciones por coronavirus relacionadas [incluido el coronavirus del síndrome respiratorio agudo severo (SARS-CoV) y el coronavirus del síndrome respiratorio del Medio Oriente (MERS-...

Advances in Contraception - New generation oral contraceptives, contraceptive Clinical experience with class 20 Surgical Contraception, Contraception and Breastfeeding.

Objective: To describe maternal characteristics and management of therapeutic abortion in women treated in a level III hospital in Peru, during 12 years of experience. Materials and Methods: Observational and retrospective study. All pregnant women who had a therapeutic interruption of pregnancy participated. The medical history of patients treated at the National Maternal Perinatal Institute of Peru, between 2009 and 2020 was reviewed. Results: 385 pregnant women were attended. The mean age was 30.4 years; 45% were nulliparous; and 51% had between 19 and 22 weeks of gestation. The causes were 7.5% due to risk of the life of the pregnant woman and 92.5% due to risk in the physical and mental health of the pregnant woman. 30% presented fetuses with multiple malformations. Uterine curettage was performed in 81%, 15.6% manual vacuum aspiration, six cases of hysterotomy. There were no cases ...

Objective: To describe maternal characteristics and management of therapeutic abortion in women treated in a level III hospital in Peru, during 12 years of experience. Materials and Methods: Observational and retrospective study. All pregnant women who had a therapeutic interruption of pregnancy participated. The medical history of patients treated at the National Maternal Perinatal Institute of Peru, between 2009 and 2020 was reviewed. Results: 385 pregnant women were attended. The mean age was 30.4 years; 45% were nulliparous; and 51% had between 19 and 22 weeks of gestation. The causes were 7.5% due to risk of the life of the pregnant woman and 92.5% due to risk in the physical and mental health of the pregnant woman. 30% presented fetuses with multiple malformations. Uterine curettage was performed in 81%, 15.6% manual vacuum aspiration, six cases of hysterotomy. There were no cases ...

Objective: To describe the epidemiological characteristics, contraception and psychological well-being in a series of women two years after therapeutic abortion. Materials and methods: Observational, descriptive study of a series of cases. The women whose therapeutic abortion procedure was performed at the National Maternal Perinatal Institute of Peru in 2018 participated and who at the time of the interview had passed two years, with prior informed consent. Sociodemographic data, obstetric profile, family planning method before therapeutic abortion and current were collected. The BIEPS Scale was applied to measure the psychological well-being of the participants two years after therapeutic abortion. Descriptive analysis was carried out and the identity of the participants was safeguarded. Results: 12 women were studied two years after presenting therapeutic abortion. At the ti...

Objective: To describe the prevalence and characteristics of seropositive pregnant women for SARS-CoV-2. Material and methods: Quantitative, cross-sectional and descriptive study. Performed in pregnant women screened for SARS-CoV-2 who met selection criteria at hospital admission. Variables of maternal characteristics, pregnancy complications and newborn condition were collected from the respective medical history. Data analysis was performed using descriptive statistics and 95% confidence intervals. Results: 1477 pregnant women admitted to hospitalization were screened, identifying a seroprevalence of anti-SARS-CoV-2 antibodies in 5.28% (95% CI: 4.22% -6.57%). Among the cases of positive seroprevalence, IgM 11.5% (95% CI: 5.7% -21.3%), IgM / IgG 64.1% (95% CI: 5.7% -21.3%), IgG 19% (95% CI: 15.7% and 35.6) were observed %), 91% of seropositive pregnant women were asymptomatic, 40% of se...

Objective: To describe the prevalence and characteristics of seropositive pregnant women for SARS-CoV-2. Material and methods: Quantitative, cross-sectional and descriptive study. Performed in pregnant women screened for SARS-CoV-2 who met selection criteria at hospital admission. Variables of maternal characteristics, pregnancy complications and newborn condition were collected from the respective medical history. Data analysis was performed using descriptive statistics and 95% confidence intervals. Results: 1477 pregnant women admitted to hospitalization were screened, identifying a seroprevalence of anti-SARS-CoV-2 antibodies in 5.28% (95% CI: 4.22% -6.57%). Among the cases of positive seroprevalence, IgM 11.5% (95% CI: 5.7% -21.3%), IgM / IgG 64.1% (95% CI: 5.7% -21.3%), IgG 19% (95% CI: 15.7% and 35.6) were observed %), 91% of seropositive pregnant women were asymptomatic, 40% of se...

Introduction: COVID-19 disease spreads rapidly. Seroprevalence in pregnant women entering for hospitalization and clinical characteristics in this type of population in Peru is not known. Objective: To determine the prevalence and clinical-epidemiological characteristics of pregnant women with anti-SARS-CoV-2 antibodies at a level III hospital in Peru. Methods: Observational and cross-sectional study performed at the National Maternal Perinatal Institute of Peru. Pregnant women admitted for hospitalization were screened for COVID-19 infection. Results of anti-SARSCoV-2 serological tests and information on maternal and perinatal characteristics were obtained. Data analysis was performed using descriptive statistics and 95% confidence intervals. Results: In 2 419 pregnant women screened we identified a prevalence of 7.0% of anti-SARS-CoV-2 antibodies (95% IC: 6.1% to 8.1%), including IgM i...

Objetivo: Comparar los resultados del embarazo entre mujeres con y sin COVID-19 atendidas en un hospital nacional de nivel III de Perú. Método: Estudio observacional, retrospectivo y comparativo. Participaron gestantes con RT-PCR positiva y negativa en razón 1:1, y 1:2 con gestantes del año 2019. Se recogió información materna y perinatal. Se usó la prueba exacta de Fisher con significancia de 0,05 y razones de prevalencia (RP) con intervalo de confianza del 95% (IC95%). Resultados: Participaron 51 gestantes con RT-PCR positiva, 51 gestantes con RT-PCR negativa y 102 gestantes del año 2019. Se observó asociación entre los resultados de la RT-PCR y el parto pretérmino (p < 0,05). La RP de parto pretérmino en las gestantes con RT-PCR positiva fue de 3,14 (IC95%: 1,29-7,64) veces en comparación con las gestantes de 2019 y de 4,0 (IC95%: 1,13-14,17) veces en comparación con las...

Introducción. La enfermedad de COVID-19 se propaga rápidamente. Se desconoce la seroprevalencia en mujeres embarazadas que ingresan a hospitalización y sus características propias en este tipo de población en Perú. Objetivo. Determinar la prevalencia y características clínico-epidemiológicas de gestantes con anticuerpos anti-SARS-CoV-2 en un hospital nivel III de Perú. Métodos. Estudio observacional de tipo transversal, realizado en el Instituto Nacional Materno Perinatal de Perú, entre el 15 de abril y 15 de mayo de 2020. Participaron todas las gestantes que ingresaron a hospitalización y fueron tamizadas para la infección por SARS-CoV-2 mediante pruebas serológicas, cuyos resultados fueron analizados conjuntamente con sus características clínicas y epidemiológicas, utilizando estadígrafos descriptivos e intervalos de confianza al 95%, y mediante la prueba de independ...